VERICEL CORPORATION financials

VCEL CIK 0000887359

Source: EDGAR filings · Built 2026-06-02T04:18:35Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 24.75M -5.81M 15.30M 10.09M 21.13M 14.95M
EBITDA 22.59M 10.02M -1.83M -13.08M -4.89M 4.75M
Working Capital 198.29M 162.49M 159.88M 149.40M 132.41M 101.08M
Net Debt -3.20M 25.02M 18.95M -3.46M -18.15M 19.68M
Gross Margin 74.42% 72.55% 68.64% 67.07% 69.26% 69.06%
Operating Margin 4.00% 1.91% -3.27% -10.42% -5.13% 1.94%
Net Margin 5.98% 4.37% -1.61% -10.21% -4.88% 2.35%
Return on Equity (ROE) 4.66% 3.55% -1.41% -8.69% -4.38% 2.13%
Return on Assets (ROA) 3.39% 2.39% -0.90% -6.12% -3.07% 1.39%
Current Ratio 5.03× 4.23× 4.49× 4.99× 6.08× 5.50×
Debt-to-Equity 0.27× 0.34× 0.39× 0.25× 0.29× 0.40×
Effective Tax Rate 4.94% 1.41% -34.38% -4.51% 1.46% 5.91%
Cash Conversion Ratio 3.14× 5.61× -11.10× -1.06× -3.89× 6.14×
Accruals Ratio -0.07× -0.11× -0.11× -0.13× -0.15× -0.07×
SBC % of Revenue 14.03% 15.38% 16.37% 22.71% 22.42% 11.35%
CapEx Coverage 1.91× 0.91× 1.76× 2.33× 3.67× 6.69×
Free Cash Flow Per Share $0.47 $-0.11 $0.32 $0.21 $0.45 $0.32

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 112.53× 274.55× 514.67×
P/FCF 75.89× 110.76× 123.03× 86.45× 97.69×
FCF Yield 1.32% 0.90% 0.81% 1.16% 1.02%
EV / EBITDA 80.56× 274.38× 301.60×
P/S 6.60× 11.49× 8.62× 7.60× 12.04× 11.60×
P/B 5.14× 9.33× 7.54× 6.47× 10.81× 10.54×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 276.26M 237.22M 197.52M 163.70M 153.07M 121.97M
Revenues 276.26M 237.22M 197.52M 164.37M 156.18M 124.18M
Cost of Goods and Services Sold 70.66M 65.12M 61.94M 54.58M 50.16M 39.95M
Gross Profit 205.60M 172.11M 135.58M 109.79M 106.03M 84.23M
Research and Development Expense 27.56M 24.80M 21.04M 19.94M 16.29M 13.02M
Selling, General and Administrative Expense 166.99M 142.79M 121.00M 106.90M 97.59M 68.84M
Operating Expenses 194.56M 167.59M 142.04M 126.85M 113.88M 81.86M
Operating Income (Loss) 11.04M 4.52M -6.46M -17.06M -7.85M 2.37M
Income Tax Expense (Benefit) 859.00K 148.00K 814.00K 721.00K -111.00K 180.00K
Net Income (Loss) Attributable to Parent 16.52M 10.36M -3.18M -16.71M -7.47M 2.86M
Earnings Per Share, Basic $0.33 $0.21 $-0.07 $-0.35 $-0.16 $0.06
Weighted Average Number of Shares Outstanding, Basic 50.34M 48.85M 47.59M 47.13M 46.47M 45.22M
Earnings Per Share, Diluted $0.32 $0.20 $-0.07 $-0.35 $-0.16 $0.06
Weighted Average Number of Shares Outstanding, Diluted 52.15M 51.68M 47.59M 47.13M 46.47M 47.28M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 100.09M 74.52M 69.09M 51.07M 68.33M 33.62M
Assets, Current 247.44M 212.78M 205.63M 186.87M 158.46M 123.56M
Assets 487.97M 432.72M 353.66M 273.00M 243.71M 205.61M
Liabilities, Current 49.15M 50.29M 45.75M 37.46M 26.05M 22.48M
Liabilities 133.33M 140.75M 127.70M 80.73M 73.24M 71.35M
Stockholders' Equity Attributable to Parent 354.64M 291.97M 225.95M 192.27M 170.46M 134.26M
Common Stock, Shares, Outstanding 50.62M 49.63M 47.83M 47.25M 46.88M 45.80M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 51.91M 58.16M 35.31M 17.69M 29.04M 17.57M
Payments to Acquire Property, Plant, and Equipment 27.16M 63.97M 20.01M 7.60M 7.92M 2.63M
Net Cash Provided by (Used in) Investing Activities -43.94M -79.03M -3.13M -36.21M -3.50M -17.16M
Net Cash Provided by (Used in) Financing Activities 7.07M 19.05M 3.62M 1.04M 9.17M 6.44M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (VCEL CIK 0000887359), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AKTS

Aktis Oncology, Inc.

FTI

TechnipFMC plc

PIII

P3 Health Partners Inc.